Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects (NSERC partnered)

University of Toronto

$282,900.00

Rapid gene expression and protein profiling for transplantation medicine

EF 2012-13

Résumé
Lung transplantation (LTx) is a life-saving therapy for patients suffering from end-stage lung disease. While there have been significant advances in procedures for lung transplantation, there are still significant impediments that stand in the way of successful transplantation outcomes. While the number of patients in need of LTx is significantly increasing, the number of donors remains static. The shortage is further aggravated by very low utilization rates of donor lungs (~15%) among multi-organ donors due to the conservative practices of many transplant groups. Recently, a set of markers were identified by co-PIs Keshavjee, Liu and Cypel that provide a molecular basis for better predicting the quality of donor lungs and thus transplant outcomes. The challenge of using these molecular markers, however, is that they must be assessed rapidly in order for this information to be used. After removal from a donor, lungs must be transplanted within 8 hours, and the clock on the use of the lung may start at times when the services of laboratories equipped to perform molecular analysis are not available. An ideal solution would be an automated testing unit that could perform rapid analysis of marker levels at the site where the donated organs are being assessed and retrieved. A new molecular analysis platform recently developed by Kelley and Sargent will provide a solution enabling marker analysis for organ transplantation. The platform is based on an electronic chip that is highly robust, inexpensive, and straightforward to fabricate. This project will adapt the chip-based detection platform described above for the challenge of transplantation medicine. The automated, highly multiplexed, fast and portable nature of this molecular diagnostic platform makes it an ideal fit for rapid readout of markers predicting lung transplant outcomes. The primary deliverable to be obtained with this support is an integrated protein/RNA detection system for transplantation medicine.
Programme
Collaborative Health Research Projects (NSERC partnered)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
270127
Name
Kelley Shana O
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Instname2
Genetics
Theme2
Biomedical
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
Rapid gene expression and protein profiling for transplantation medicine
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$282,900
Cihrequipment2
$0
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Biomarkers; Biosensing; Microchip Technology; Transplantation Medicine
Abstract
Lung transplantation (LTx) is a life-saving therapy for patients suffering from end-stage lung disease. While there have been significant advances in procedures for lung transplantation, there are still significant impediments that stand in the way of successful transplantation outcomes. While the number of patients in need of LTx is significantly increasing, the number of donors remains static. The shortage is further aggravated by very low utilization rates of donor lungs (~15%) among multi-organ donors due to the conservative practices of many transplant groups. Recently, a set of markers were identified by co-PIs Keshavjee, Liu and Cypel that provide a molecular basis for better predicting the quality of donor lungs and thus transplant outcomes. The challenge of using these molecular markers, however, is that they must be assessed rapidly in order for this information to be used. After removal from a donor, lungs must be transplanted within 8 hours, and the clock on the use of the lung may start at times when the services of laboratories equipped to perform molecular analysis are not available. An ideal solution would be an automated testing unit that could perform rapid analysis of marker levels at the site where the donated organs are being assessed and retrieved. A new molecular analysis platform recently developed by Kelley and Sargent will provide a solution enabling marker analysis for organ transplantation. The platform is based on an electronic chip that is highly robust, inexpensive, and straightforward to fabricate. This project will adapt the chip-based detection platform described above for the challenge of transplantation medicine. The automated, highly multiplexed, fast and portable nature of this molecular diagnostic platform makes it an ideal fit for rapid readout of markers predicting lung transplant outcomes. The primary deliverable to be obtained with this support is an integrated protein/RNA detection system for transplantation medicine.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kelley, Shana O; Keshavjee, Shaf
Approvedterm
3 ans 0 mois
Cihrcontribution2
Knowledge Translation Branch~ $282,900~ $0~